Equity Details
Price & Market Data
Price: $2.43
Daily Change: -$0.03 / 1.23%
Daily Range: $2.22 - $2.89
Market Cap: $3,759,178
Daily Volume: 58,042
Performance Metrics
1 Week: -12.27%
1 Month: 9.95%
3 Months: 15.85%
6 Months: -12.92%
1 Year: -52.82%
YTD: -13.52%
About XORTX Therapeutics Inc. (XRTX)
Comprehensive analysis of XORTX Therapeutics Inc. (XRTX). Currently at 2.43, with a daily change of -$0.03 / 1.23%. Market cap: 3,759,178. Evaluate its performance over YTD, 1-month, and 6-month periods.
Details
XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat hyperuricemia related diseases in Canada. It develops XRx-026, which is in Phase III for the treatment of gout; XRx-008, which is in Phase II for the treatment of autosomal dominant polycystic kidney disease; XRx-101, which is in Phase II for the treatment of acute kidney injury associated with respiratory virus infection, including sepsis and coronavirus; and XRX-225, which is in preclinical stage for the treatment of type 2 diabetic nephropathy, as well as VB4-P5, a program for the treatment and prevention of fibrosis in the kidney. The company is based in Calgary, Canada.